trending Market Intelligence /marketintelligence/en/news-insights/trending/yexupX5wxOMhQkJC5x9ISA2 content esgSubNav
In This List

Celldex Therapeutics appoints board member

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Celldex Therapeutics appoints board member

Celldex Therapeutics Inc. appointed Gerald McMahon to its board of directors.

Board member Richard van den Broek resigned, "due to increasing responsibilities in other endeavors," the company said.

McMahon was previously the president and CEO of Kolltan Pharmaceuticals.

Hampton, N.J.-based Celldex develops therapeutics for the immune system.